Bold takeaway: Genetics increasingly shapes how we breed performance horses, but the science reveals a nuanced truth—there are no perfect shortcuts, only smarter trade‑offs.
Producing a top performance horse means carefully balancing athletic potential, health, and temperament. It’s a tall order because success hinges on fine‑tuned combinations of traits, and progress can take years or even decades. Traditionally, breeders relied on pedigrees, physical conformation, past performance, temperament, and hands‑on experience to pair horses likely to produce exceptional foals.
Over roughly 4,500 years, horses have evolved from wild ancestors into the specialized athletes we know today. Yet the process remains slow and, at times, error‑prone, notes Ted Kalbfleisch, PhD, at the University of Kentucky’s Gluck Equine Research Center. When the first horse genome was mapped in 2007, the industry hoped to pivot toward a gene‑driven, more precise breeding approach. Since then, researchers have sequenced DNA from thousands of horses, uncovering genetic differences linked to coat color, performance, temperament, and numerous heritable diseases.
Samantha A. Brooks, PhD, from the University of Florida, states that this progress ushers in a new era of breeding—one that emphasizes precision, higher success rates, and more ethical choices. With education and a blood sample sent to a qualified lab, breeders can understand the genes circulating in their programs and learn how to combine them in the smartest, healthiest, and most ethical ways possible.
The Genes of Performance in Horses
Within a year of genome mapping, attention turned to the myostatin gene (MSTN). Already studied in human athletes and racing dogs, MSTN variants influence muscle fiber development and musculature. Researchers found the equine MSTN gene and began comparing its variants with racing performance. Over time, MSTN emerged as a kind of switch: some variants favor sprinting, others endurance.
“It’s not that one allele is inherently better than another,” explains Brooks. “They simply enable fine‑tuning.”
Genome‑wide association studies (GWAS) have identified several candidate genes linked to performance in top racehorses, such as COX4I2 (involved in mitochondrial respiration) and PDK4 (believed to influence behavior). Yet the bigger picture is intricate: genes often interact with one another and with non‑genetic factors, cautions Kalbfleisch.
Meanwhile, Swedish researchers highlighted DMRT3, dubbed the gait keeper gene. Variants can produce a truncated protein that alters movement patterns, enabling lateral gaits in Icelandic horses, Saddlebreds, and other gaited breeds. Importantly, DMRT3 variants also help prevent trot‑racing horses from breaking into a gallop. Years of study showed that DMRT3 influences gait quality at the trot and gallop across breeds.
More recent work, including Icelandic studies, reinforces that the picture is complex. DMRT3 appears to interact with other genes such as STAU2 and RELN to influence tölt, pace, trot, canter, and gallop, while RELN may affect how trainable young horses are. Regions linked to back and croup conformation also influence gait, underscoring the role of neuromotor and skeletal genes.
Performance in disciplines beyond racing adds even more layers. Show jumpers often benefit from variants affecting mentality, brain signaling, neuromuscular coordination, and muscle development. Cutting horses differ from racing Quarter Horses in genes related to muscle growth, skeletal development, energy metabolism, cardiovascular traits, and nervous system function.
Temperament genetics add another dimension by shaping how horses cope with training and competition pressures. Environmental factors—nutrition, welfare, training, and management—play substantial roles as well. “We’d all love a crystal ball that says, ‘This horse will be great at dressage, jumping, racing, or another discipline,’” says Annette McCoy, DVM, MS, PhD. “But performance is not a single, simple trait; it’s a complex, multi‑layered topic.”
The Genes of Health and Disease in Horses
In contrast to performance traits, many health‑related genes are more straightforward. Global databases catalog hundreds of heritable traits and their specific variants, with the majority linked to health concerns. Scientists can now identify genetic variants that cause conditions such as fragile foal syndrome (FFS), polysaccharide storage myopathy (PSSM1/PSSM2), hereditary equine regional dermal asthenia (HERDA), degenerative suspensory ligament desmite (DSLD), hyperkalemic periodic paralysis (HYPP), glycogen branching enzyme deficiency (GBED), and glycogen storage disease type IV. These variants are readily testable.
This is especially critical because some diseases co‑occur with performance traits. For example, connective tissue disorders like FFS and HERDA may coincide with the elasticity of movement desirable in Warmbloods and stock horses. “Strong selective pressure can increase the frequency of these issues because of performance preferences,” Brooks notes. “But altering connective tissue elasticity can impact other body systems.”
Researchers are also pursuing genetic contributors to musculoskeletal health to reduce catastrophic racetrack injuries. A promising candidate is the ZNF804A gene. Scientists are exploring links to heart defects as well, which could help identify horses at risk of sudden collapse.
“I hope the field shifts toward protecting equine athletes by breeding selectively for traits that lower injury risk,” says Lynn Pezzanite, DVM, MS, PhD, Dipl. ACVS. “The ultimate aim is to improve welfare as well as performance.”
Take‑Home Message
Today’s breeders combine practical experience with genomic tools to give future equine athletes the best possible start. With accessible tests and expanding genetic insight, identifying health risks early and making informed breeding decisions has become more feasible.
Genetic testing enables breeders to select for desirable traits while minimizing the risk of potentially catastrophic inherited diseases that can lead to heartbreak. “The main gap now is in application and in helping owners and breeders understand how to use these tools,” Brooks notes.
With these tools, breeders can support not only exceptional performance but also healthier, happier horses. “Promoting welfare should be the top priority,” emphasizes Pezzanite.
The abstract “Shear Stiffness of Equine Synovial Membrane in Osteoarthritis And Response to 2.5% Injectable Polyacrylamide Hydrogel Treatment” was part of the International Cartilage Regeneration & Joint Preservation Society World Congress, and the proceedings are not yet available.
